European Pharmaceutical Review

JUNE 24, 2022

Following initial consultations in 2021, we expect the publication of the proposal for changes to the EU’s pharmaceutical legislation and potential adoption by the European Commission (EC) by December 2022. He focuses his practice on EU regulatory affairs, litigation and competition law issues affecting the life sciences sector in Europe.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. About the author. She joined NSF in 2017.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

European Pharmaceutical Review

AUGUST 23, 2022

Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. In addition, he was Head of the Legal Service at the European Medicines Agency from 2004 to 2012.

Consulting 98

Consulting Medical Healthcare Healthcare 98

PM360

SEPTEMBER 28, 2022

PM360 spoke to Kokino about the evolution of the biosimilars market from its nascent days, why the now increased competition within the market is causing some companies to reconsider developing biosimilars, what to look for over the next few years, and how Accord’s approach is a bit different from what other companies are doing.

Competition 98

Competition Marketing Manufacturing Biopharma 98

Pharmaceutical Technology

OCTOBER 5, 2022

As per the US Department of Justice, Biogen paid remuneration in the form of training and consulting fees and speaker honoraria, to induce physicians to prescribe the company’s drugs, in violation of the Anti-Kickback Statute. More recently, Biogen has been facing competition from dimethyl fumarate generics.

Government 59

Government Specialization Physicians Marketing 59

European Pharmaceutical Review

FEBRUARY 7, 2023

Following publication of the proposal, the European Commission launched an eight-week public consultation. The stakeholder consultation resulted in 246 comments and ended on 18 January 2023. However, the eight-week period was quickly shortened to eight days.

Medical 117

Medical Government Marketing Medicine 117

European Pharmaceutical Review

JULY 4, 2024

4,6 Traditional Herbal Registration The Traditional Herbal Medicines Directive (Directive 2004/24/EC) is implemented in the UK by the Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005 and came into force on 30 April 2011. Premier Consulting [Internet]. 2012/1916). 2018 [cited 2024May]. Ethnopharmacol.

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103